© 2003 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher.
The content and opinions expressed in this book are the sole work of the authors and editors, who have warranted due diligence in the creation and issuance of their work. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences arising from the information or opinions presented in this book and make no warranty, express or implied, with respect to its contents.
Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication.
For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel.: 973-256-1699;Fax: 973-256-8341; E-mail: [email protected]manapr.com or visit our website: http://humanapress.com
The opinions expressed herein are the views of the authors and may not necessarily reflect the official policy of the National Institute on Drug Abuse or any other parts of the US Department of Health and Human Services. The US Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this publication are used only because they are considered essential in the context of the studies reported herein.
This publication is printed on acid-free paper. (3
ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials. Photocopy Authorization Policy:
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $8.00 per copy, plus US $00.25 per page, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is: [0-89603-879-3/03 $10.00 + $00.25].
Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1
Glutamate and addiction / edited by Barbara H. Herman; coeditors, Jerry Frankenheim...[et al.]. p.;cm.-(Contemporary clinical neuroscience) Includes bibliographical references and index. ISBN 0-89603-879-3 (alk. paper)
1. Substance abuse-Pathophysiology. 2. Glutamic acid-Physiological effect. I. Herman, Barbara H. II. Frankenheim, Jerry. III. Series.
[DNLM: 1. Substance-Related Disorders-physiopathology. 2. Glutamates-pharmacology. 3. Receptors, Glutamates-physiology. WM 270 G567 2002] RC564.G585 2002
This book is dedicated to our families and collaborators who contributed and supported this effort to characterize the role of glutamatergic systems in addiction disorders and to develop new technologies for the treatment of these brain disorders. This book is also dedicated to Dr. Marian Fischman who died on October 23, 2001 during the final review phase of this book. Dr. Fischman's contributions to the medications development of cocaine and opiate addiction were an outstanding influence in understanding the biology and treatment of addiction disorders. Finally, this book is dedicated to the physicians Lawrence Kelley, md, Jacqueline R. Honig, md, Marc S. Myerson, md, and the countless other valued medical personnel who brought one of us back from a near death experience during its creation.
To Alexandra Samantha Herman, Robert H. Herman, Anita S. Herman
Was this article helpful?
Are you looking for a full total body detox? If so, then you might want to try a 10 day detox or some refer to it as the 2-week detox. A 10-day detox is a full body detox that usually means taking several different steps to reach your total body transformation. It might involve a change in diet, exercise and more.